A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

NCT05080959 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Inguinal Herniorrhaphy

Interventions

DRUG: CPL-01
DRUG: Naropin 150 MG Per 20 ML Injection
DRUG: Placebo

Sponsor

Cali Pharmaceuticals LLC